The reimbursement status for focused ultrasound-related procedures in the US varies among the different indications.

The following outlines the reimbursement landscape of focused ultrasound therapy for the following conditions, as of October 2020:

  • US map BlueEssential tremor is reimbursed by Medicare in all states and covered through a combination of six commercial insurance companies in 33 states.
  • Tremor-dominant Parkinson’s disease is reimbursed by Medicare in seven states, with no current commercial insurance coverage.
  • Salvage therapy for local treatment of radiorecurrent prostate cancer is covered in 10 states through Medicare and all 50 states plus Washington, DC through a combination of five commercial insurers.
  • Bone metastases has no Medicare coverage but is reimbursed in all 50 states plus Washington, DC though a combination of six commercial insurers.
  • Treatment of uterine fibroids is not covered by Medicare or commercial insurers.

See More on Reimbursement Status by Indication >

The Focused Ultrasound Foundation Newsletter

Our newsletter delivers updates for clinicians, researchers and patients. Sign up and stay on top of the rapid advancements of this innovative medical technology.

Sign Up  Read the Latest Issue

Read The Tumor  by John Grisham

From John Grisham, comes a story where today’s medical fiction could become tomorrow’s lifesaving reality.

Download a Free eBook or Audiobook

Contact Details

Call Us
Find Us
Focused Ultrasound Foundation
1230 Cedars Court, Suite 206 Charlottesville, VA 22903
Whitelist Instructions